• AddressStevenage Bioscience Catalyst Incubator Building,, Gunnels Wood Road, Stevenage, unnels Wood Road, Stevenage, Herts, SG1 2FX, London, UK
  • Websitewww.nerretherapeutics.com
  • Est. Since2012
  • InvestorsForbion

About NeRRe Therapeutics

NeRRe Therapeutics is a clinical-stage company developing orvepitant, a neurokinin (NK)-1 receptor antagonist, as a first in class, once daily breakthrough treatment for cough hypersensitivity disorders.

Jobs From NeRRe Therapeutics

No Jobs found with this criteria